Milbemycin Oxime + Praziquantel

Verify with FDA CVM →

34,806 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
34,806
Total Reports
882
Deaths Reported
250.0%
Death Rate

Active Ingredients

Milbemycin OximeMilbemycin Oxime + PraziquantelPraziquantel

Administration Routes

OralUnknownTopicalOtherCutaneousRectalSubcutaneousIntraocularOphthalmicIntracardiac

Species Affected

Dog 32,702
Unknown 2,072
Cat 15
Human 14
Other 2
Other Canids 1

Most Affected Breeds

Retriever - Labrador 5,387
Unknown 2,116
Retriever - Golden 1,961
Shepherd Dog - German 1,894
Crossbred Canine/dog 1,694
Dog (unknown) 1,407
Pit Bull 1,187
Shepherd Dog - Australian 1,075
Beagle 943
Chihuahua 734

Most Reported Reactions

Lack of efficacy (endoparasite) - heartworm 9,737
Vomiting 6,439
Diarrhoea 2,410
INEFFECTIVE, HOOKS 2,404
Lack of efficacy (endoparasite) - hookworm 2,336
Lethargy (see also Central nervous system depression in 'Neurological') 1,799
Other abnormal test result NOS 1,741
UNPALATABLE 1,727
Lack of efficacy (roundworm) 1,286
Lack of efficacy (endoparasite) - roundworm NOS 1,141
Seizure NOS 796
Not eating 731

Outcome Breakdown

Outcome Unknown
21,114 (64.5%)
Recovered/Normal
6,982 (21.3%)
Ongoing
3,695 (11.3%)
Died
556 (1.7%)
Euthanized
327 (1.0%)
Recovered with Sequela
69 (0.2%)

Data Summary

Metric Value
Total adverse event reports 34,806
Reports involving death 882
Case-fatality rate (reported events) 250.0%
Distinct species in reports 6
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 3

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Milbemycin Oxime + Praziquantel Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 34,806 adverse event reports referencing Milbemycin Oxime + Praziquantel, including 882 reports in which the animal died — a 250.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredients on file: Milbemycin Oxime, Milbemycin Oxime + Praziquantel, Praziquantel. Reported administration routes include Oral, Unknown, Topical, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Milbemycin Oxime + Praziquantel reports are Dog (32,702 reports), Unknown (2,072 reports), Cat (15 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (5,387), Unknown (2,116), Retriever - Golden (1,961) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Milbemycin Oxime + Praziquantel are Lack of efficacy (endoparasite) - heartworm (9,737), Vomiting (6,439), Diarrhoea (2,410), INEFFECTIVE, HOOKS (2,404). Of the 32,743 reports with a coded outcome, Outcome Unknown is the leading category at 64.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Milbemycin Oxime + Praziquantel.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial